Effects of Immunotherapy: Clinical Trials

1 trial for Effects of Immunotherapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow Effects of Immunotherapy: new trials by email Literature Review of Effects of Immunotherapy trials Research Report on Effects of Immunotherapy

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of Dinutuximab Combined With Immunotherapy to Treat Neuroblastoma
Dinutuximab. Immunotherapy - Neuroblastoma, Neoplasm, Residual
Phase 2CompletedFundació Sant Joan de Déu242014-11-262024-04-22

Narrower conditions

Neoplasm, Residual (1)  ·  Neuroblastoma (1)

Broader conditions

Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Germ Cell and Embryonal (1)  ·  Neoplasms, Glandular and Epithelial (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplasms, Neuroepithelial (1)  ·  Neoplastic Processes (1)  ·  Neuroectodermal Tumors (1)  ·  Neuroectodermal Tumors, Primitive (1)  ·  Neuroectodermal Tumors, Primitive, Peripheral (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Interleukin-2 (1)  ·  Isotretinoin (1)  ·  dinutuximab (1)  ·  sargramostim (1)

Sponsors

Fundació Sant Joan de Déu (1)

Countries

Spain (1)

Top investigators

Jaume Mora, MD (1)